131 results on '"Sharma, Akshay"'
Search Results
2. ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies
3. Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities
4. Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee
5. Remodeling Ca2+ dynamics by targeting a promising E-box containing G-quadruplex at ORAI1 promoter in triple-negative breast cancer
6. Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force
7. Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond
8. International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update
9. Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients
10. Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learning
11. Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
12. Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation
13. International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell–based genomic therapies and the challenges faced
14. Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis
15. Post-heating evaluation of fibre reinforced concrete with LC3 binder as replacement to OPC
16. Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
17. Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis
18. Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers
19. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
20. An experimental investigation of new roughness patterns (dimples with alternative protrusions) for the performance enhancement of solar air heater
21. An overview of deep eutectic solvents: Alternative for organic electrolytes, aqueous systems & ionic liquids for electrochemical energy storage
22. Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines
23. A comparative analysis of volumetric, viscometric and conductometric properties of Triethylmethylammonium Tetrafluoroborate (TEMABF4) and Tetraethylammonium Tetrafluoroborate (TEABF4) in pure propylene carbonate (PC) and binary aqueous propylene carbonate solvents
24. Potential of phase change materials and their effective use in solar thermal applications: A critical review
25. Utilization of Linz-Donawitz slag and brick bat for the production of sustainable paver blocks
26. Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis
27. Nomenclature for Cellular and Genetic Therapies: A Need for Standardization
28. Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
29. Does Stereoelectroencephalography Add Value in Patients with Lesional Epilepsy?
30. Investigation on the sensitivity of indentation devices for detection of fatigue loading induced damage in bovine cortical bone
31. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy
32. Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation
33. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
34. Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
35. Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis
36. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy
37. Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis
38. The Utility of Remote Video Technology in Continuing Neurosurgical Care in the COVID-19 Era: Reflections from the Past Year
39. Influence of the substrate permeability on Leidenfrost temperature
40. A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease
41. Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease
42. Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee
43. Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis
44. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
45. Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis
46. HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia
47. E3 ligase SCFSKP2 ubiquitinates and degrades tumor suppressor C/EBPα in acute myeloid leukemia
48. Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
49. Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research
50. Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.